5AM Partners VI, LLC bought CAMP

August 3, 2026 · Form 4 insider transaction

5AM Partners VI, LLC bought 3,179,558 shares of CAMP4 THERAPEUTICS CORPORATION at $1.53 per share, a transaction worth $4.86M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
3,179,558
Price
$1.53
Total value
$4.86M
Role10% owner
SecurityPre-Funded Warrant (Right to Buy)
Transaction codeP: Open-market purchase
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after3,179,558
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Pre-Funded Warrant has no expiration date and is exercisable immediately. Notwithstanding the foregoing, 5AM Ventures VII, L.P. ("Ventures VII") shall not be entitled to exercise the Pre-Funded Warrant to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by Ventures VII, together with its Attribution Parties (as defined in the Pre-Funded Warrant), to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.; The shares are directly held by Ventures VII. 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.

View the original Form 4 on SEC EDGAR
5AM Partners VI, LLC bought CAMP: August 3, 2026 | Insider Trading Screener